Objective: To investigate the presence of immunoreactivity against mycobacterial antigens in the sera of patients with rheumatoid arthritis (RA) and to detect the target of the immune reaction.
Methods: This study was carried out on 60 patients with RA, and 25 patients with no joint diseases in the laboratory of Clinical Microbiology Department of Ankara University Medical Faculty, Ankara, Turkey between July 2003 to January 2004. Secreted and cellular antigens of Mycobacterium tuberculosis (M. tuberculosis) H37Rv and Mycobacterium bovis (M. bovis) were isolated and purified by high performance liquid chromatography to antigenic fractions. The immunoreactivity of patient and control sera against these antigens were determined by enzyme-linked immunosorbent assay (ELISA).
Results: Immunoreactivity against mycobacterial antigens in RA patients were significantly higher than controls. Significant difference between patients and controls has been determined with M. bovis Bacillus Calmette Guerin (BCG) culture fluid and sonicate antigens, but not with M. tuberculosis H37Rv. This suggests that the antigen triggering immune response in patients with RA may belong to or mainly expressed on M. bovis BCG. The ELISA results showed significant difference between RA patients and controls with all antigenic fractions.
Conclusion: Presence of increased immunoreactivity against mycobacterial antigens in the sera of patients with RA was detected. When statistical analyses was considered, we cannot put forward any antigenic fraction alone as the one responsible for the increased reactivity.
Download full-text PDF |
Source |
---|
Arch Pathol Lab Med
November 2024
the Department of Pathology, University of Michigan, Michigan Medicine, Ann Arbor, Michigan (Kroll-Wheeler, Hrycaj, Chan, Cheng, Lamps).
Context.—: Recent publications have featured immunohistochemistry (IHC) as a sensitive tool for detecting Mycobacterium tuberculosis and nontuberculous mycobacteria, but performance is limited to cases suspected to have mycobacterial infection.
Objective.
Mol Biotechnol
February 2025
Department of Preventive Health Care, Ren Huai People's Hospital, 2802, Building 3, Shengjie Community Harmony Square, Luban Street, Renhuai, Zunyi, Guizhou, China.
Tuberculosis (TB) is a chronic respiratory infectious disease and is induced by Mycobacterium tuberculosis (M.tb) infection. Macrophages serve as the cellular home in immunoreaction against M.
View Article and Find Full Text PDFInt J Mycobacteriol
December 2023
Department of Immunology, Indian Council of Medical Research, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India.
Background: To combat the tuberculosis (TB) epidemic, the development of a better and faster diagnosis or more effective vaccine is essential. Pulmonary TB (PTB) is one of the major causes of morbidity and mortality. Early diagnosis of TB is difficult.
View Article and Find Full Text PDFFront Immunol
December 2023
Institute for Infection and Immunity, St. George's University of London, London, United Kingdom.
Introduction: The large family of PE and PPE proteins accounts for as much as 10% of the genome of . In this study, we explored the immunogenicity of three proteins from this family, PE18, PE31, and PPE26, in humans and mice.
Methods: The investigation involved analyzing the immunoreactivity of the selected proteins using sera from TB patients, IGRA-positive household contacts, and IGRA-negative BCG vaccinated healthy donors from the TB endemic country Mozambique.
J Vet Diagn Invest
July 2023
Infectious Diseases Pathology Branch (IDPB), Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!